Stocks To Buy Now Blog

Stocks on Radar

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Identifies Rare Earth Mineralization at Cameron Project, Expands Exploration Targets

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

  • Canadian mineral exploration company Powermax Minerals has reported soil and rock sampling results indicating rare earth element mineralization at the Cameron REE Project in British Columbia.
  • Soil samples returned Total Rare Earth Oxide (“TREO”) values ranging from 135 ppm to 2,840 ppm, outlining a mineralized corridor more than one kilometre long, with rock sampling returning values up to 741 ppm TREO, supporting the potential presence of REE-bearing bedrock.
  • Results suggest REE mineralization associated with NYF-type pegmatites, a geological setting known to host rare earth deposits, and identify multiple areas for follow-up exploration and potential drilling.

Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company focused on critical rare earth elements, has reported encouraging early exploration results from its Cameron Rare Earth Element Project in British Columbia. Recent soil and rock sampling programs at the project have identified multiple areas of anomalous rare earth element mineralization associated with pegmatite systems, according to a company announcement (https://ibn.fm/oehFU).

The Cameron project is located roughly 40 kilometers south of Revelstoke in British Columbia, along Highway 23 near the Columbia River. The property spans approximately 2,984 hectares within the Kamloops Mining Division. Powermax recently conducted a soil geochemical survey across priority areas of the property. The program returned Total Rare Earth Oxide (“TREO”) values ranging from approximately 135 parts per million to 2,840 ppm, with an average value of about 340 ppm TREO. Several samples recorded anomalous values above 400 ppm TREO, and the highest sample reached 2,840 ppm TREO.

The results outlined a north–south trending corridor of elevated rare earth values extending for more than one kilometre. The anomalous zone coincides with mapped pegmatites and historically documented thorium-uranium mineralization associated with the Cameron (Jenkins) showing areas.

Clusters of the strongest anomalies occur within the Cameron REE 2 claim block, suggesting a potential bedrock source of rare earth mineralization beneath shallow overburden.

Follow-up prospecting programs focused on exposed pegmatite outcrops and mineralized float across the property. Surface rock sampling returned TREO values ranging from less than 36 ppm to 741 ppm TREO, with several samples exceeding 100 ppm TREO. The highest value recorded was 741 ppm TREO, while additional samples returned values between 526 ppm and 741 ppm TREO.

These anomalous rock samples cluster in areas along the Highway 23 corridor within the Cameron REE 3 claim block, as well as near the Cameron (Jenkins 1) showing.

The spatial relationship between soil anomalies and mineralized rock samples suggests the presence of rare earth-bearing pegmatite bodies in bedrock underlying the geochemical anomalies. Because the samples were selective grab samples, they are not considered representative of average mineralization grades across the property.

The exploration results point toward mineralization associated with NYF-type pegmatites, a class of pegmatites enriched in elements such as niobium, yttrium, fluorine and rare earth elements. These pegmatites occur within the broader Monashee geological terrane, a metamorphic and granitic region known to host pegmatitic intrusions and structurally controlled mineralization.

At Cameron, rare earth mineralization appears linked to shear zones and pegmatite intrusions enriched in both light rare earth elements (“LREE”) and heavy rare earth elements (“HREE”). According to the company, the correlation between soil anomalies, rock sampling results, and previously reported stream sediment results strengthens the exploration model for the project.

Management says the next phase of exploration will focus on identifying the underlying bedrock sources responsible for the surface geochemical anomalies. Future programs may include additional mapping, trenching, and drilling to test the most prospective targets.

Powermax’s Chief Executive Officer Paul Gorman reiterated the importance of the Cameron Property results by stating. “The strong correlation between soil geochemical anomalies and anomalous REE values from surface rock and previously reported stream sediment sampling indicates the potential for a pegmatite system prospective for REE mineralization on our property. Our upcoming exploration program will focus on defining the bedrock sources of these anomalies and advancing the most prospective targets toward drilling.” 

Powermax’s exploration work comes as governments and industries are seeking alternative supply chains for rare earth elements used in advanced technologies. Rare earth elements are essential components in electric vehicle motors, wind turbines, electronics and defense systems.

Global demand for rare earth oxides is projected to rise significantly in the coming decade, driven in part by the electrification of transportation and expansion of renewable energy infrastructure. 

At present, China controls a large share of global rare earth production and an even larger portion of processing capacity. This concentration has prompted Western governments to support the development of domestic or allied supply chains. In the United States, for example, federal initiatives under the Defense Production Act have directed more than $1 billion toward strengthening rare earth supply chains and supporting new production. Canadian projects are also viewed as potential contributors to future North American supply.

In addition to the Cameron project, Powermax Minerals Inc. holds exploration interests in several rare earth projects across North America. These include the Atikokan REE property in northwestern Ontario and the Pinard REE project in northern Ontario. The company also owns a 100% interest in the Ogden Bear Lodge Project in Wyoming.

For more information, visit the company’s website at www.PowermaxMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to PWMXF are available in the company’s newsroom at https://ibn.fm/PWMXF

Exploration Target Cautionary Statement

The exploration targets discussed are conceptual, and there is currently not enough data to confirm a mineral resource. Further exploration may not yield successful results.

Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline

  • High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology.
  • Soligenix is leveraging its platform science to expand the therapeutic reach of its development programs and explore additional disease indications.
  • The broader emphasis of Soligenix’s platform science approach is to maximize the scientific value of its research infrastructure.

Medical progress has transformed the treatment of many common illnesses, yet thousands of rare diseases still lack effective therapies. Companies working at the intersection of biotechnology innovation and rare disease research are increasingly focused on addressing these gaps, including Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing and commercializing therapies and vaccines for rare diseases and unmet medical needs.

The need for sustained development in rare disease medicine is significant. While each condition may affect a relatively small number of individuals, the collective impact is significant. According to the U.S. National Institutes of Health, rare diseases affect an estimated 25 million to 30 million Americans, illustrating that these conditions represent a major public-health challenge despite their individual rarity. Similarly, the U.S. Food and Drug Administration reports that more than 10,000 rare diseases have been identified, affecting roughly one in ten people in the United States.

Despite this widespread impact, therapeutic development remains limited — and essential. The National Organization for Rare Disorders notes that only a small fraction of rare diseases currently have approved treatments, leaving the majority of patients without targeted therapeutic options. Developing therapies for these conditions can be particularly challenging because patient populations are small and the underlying biology of many diseases is not yet fully understood. Clinical trials are often more complex to design and conduct, requiring innovative scientific approaches and specialized expertise.

For these reasons, high-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. By leveraging platform technologies, companies can apply core scientific capabilities across multiple therapeutic programs, improving efficiency and enabling the exploration of treatments for diseases that might otherwise remain neglected. These approaches can accelerate the discovery and development process, making it more feasible to address smaller patient populations while maintaining rigorous standards for safety and efficacy.

Soligenix is among the companies applying this platform-driven strategy to rare disease research. The company is leveraging its platform science to expand the therapeutic reach of its development programs and explore additional disease indications. The strategy reflects a broader effort to build on core technologies that can support multiple product candidates across different rare and neglected conditions.

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases as well as certain inflammatory and infectious conditions. The company’s development programs span two primary segments: specialized biotherapeutics and public health solutions. Within the rare disease category, its pipeline includes therapies designed to address conditions that currently have limited treatment options.

The company’s strategy centers on leveraging established scientific platforms that can be adapted for multiple therapeutic applications. By using a platform-based approach, Soligenix aims to streamline development while expanding the potential reach of its technologies. This method allows researchers to apply existing expertise and scientific insights to new disease targets, potentially accelerating progress across multiple programs simultaneously.

Among the company’s notable development efforts is HyBryte(TM), a photodynamic therapy designed for the treatment of cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that affects the skin. The therapy combines synthetic hypericin with visible light activation and has been studied as a novel approach for treating early-stage disease. Programs such as this highlight the company’s focus on rare and difficult-to-treat conditions where new therapeutic approaches could provide meaningful benefits for patients.

Beyond individual programs, the broader emphasis of Soligenix’s platform science approach is to maximize the scientific value of its research infrastructure. By applying core technologies across multiple programs, the company seeks to enhance development efficiency while supporting the exploration of additional therapeutic indications. This strategy may enable the company to pursue multiple rare disease opportunities while maintaining a focused research framework.

The company’s platform capabilities allow it to extend scientific insights beyond a single therapy or disease target. In practice, this means that discoveries or innovations developed in one program can potentially inform additional research areas, creating opportunities for expanded therapeutic development. Such cross-program synergy is increasingly important in rare-disease research, where scientific breakthroughs often depend on specialized knowledge and long-term investment.

As biotechnology innovation continues to evolve, platform-driven development strategies are becoming a defining feature of companies working in rare disease medicine. The ability to build multiple therapies from a shared scientific foundation can improve development efficiency and broaden the potential impact of research investments.

For Soligenix, leveraging platform science represents a pathway toward expanding its pipeline while continuing to focus on diseases that historically have received limited attention. By combining specialized research capabilities with a platform-based development model, the company is positioning itself to pursue new therapeutic opportunities while contributing to the broader effort to address the unmet medical needs faced by patients with rare diseases.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Prepares for Gold Pour and Anticipates Straightforward Path to Profitability with Positive PEA

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

  • Recent analysis by Zacks Small Cap Research underscores the positive strategic position of Canadian gold developer LaFleur Minerals as it prepares to restart gold production at its Beacon Gold Mill this year
  • LaFleur’s assets include its wholly owned Beacon Gold Mill, nearby district-scale Swanson Gold Deposit within the renowned Abitibi belt, and a strategic proximity to skilled labor and equipment suppliers in the already established Val d’Or, Quebec mining camp
  • LaFleur recently completed a Preliminary Economic Assessment (“PEA”) that outlining the potential for profitability thanks to its scalable mining project and established processing infrastructure, highlighted by a rapid payback period and capital efficiency with expected 65% IRR after taxes
  • LaFleur updated its 2024 mineral resource estimate (“MRE”) with a 30% increase in the indicated MRE category to over 160,000 ounces of contained gold, and to over 66,000 ounces of contained gold in the inferred category

A recently completed Preliminary Economic Assessment (“PEA”) is substantiating near-term gold producer LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF)‘s profile as a junior gold developer positioned to capitalize on the pairing of its scalable Swanson Gold Deposit and its fully permitted Beacon Gold Mill in Eastern Canada’s Tier‑1 Abitibi gold belt, as it prepares to restart gold production during Q2-2026.

The PEA highlights the project’s capital efficiency and economic returns that are anticipated to be significant, particularly at market prices recorded throughout 2025 and into 2026. The PEA establishes a Net Present Value (“NPV”) of C$101 million (5% value creation) and places Internal Rate of Return (“IRR”) expectations at 65% after taxes — highlighting a potential investment profitability that features quick payback and a competitive base-case IRR when compared to peers.

The PEA’s All-In Sustaining Costs (“AISC”) conservative metric sustains that even if gold prices trending around $5,000 per ounce this year were to retreat as far as $2,750 per ounce, the project would remain profitable. “For investors, the combination of a validated mine plan, a permitted processing facility, and a strengthening gold market creates a compelling setup for value realization over the next 12–24 months,” recent analysis by Zacks Small Cap Research states (https://ibn.fm/swGNK).

“Operational readiness is another differentiator,” the report adds. “The Beacon Gold Mill is fully permitted, refurbished, and funded for restart following a C$7 million financing. … With multiple catalysts ahead, including ongoing drill results, bulk sample approval, and mill commissioning, the company is positioned for a meaningful re-rating as it advances toward production.”

The company’s updated 2026 mineral resource estimate (“MRE”) preceded positive results from recently completed diamond drilling but still increased the indicated mineral resource from the 2024 findings by 30% to ~160,300 ounces of contained gold in the indicated category and ~66,800 ounces of contained gold in the inferred category (https://ibn.fm/ylqOi).

The indicated resource favors the company’s open pit strategy at low operational cost over years compared to the eventual transition to exploring the project’s underground potential. The mineralized footprint remains “open in all directions, and ongoing drilling continues to demonstrate extensions at depth, on strike, and internally within the deposit,” Zacks notes.

LaFleur is focused on continued technical optimization, metallurgical and bulk sample validation, and permitting advancement for restarting gold production at the Beacon Mill this year, with about 30% of the budget spent to ready the facility for a planned gold pour in the coming months.

The strategy establishes LaFleur Minerals as a company with a clear path to production, existing processing assets and the potential for pipeline resource growth.

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://ibn.fm/LFLRF

Qualified Person Statement:

All scientific and technical information contained in this article has been reviewed and approved by Louis Martin, P.Geo. (OGQ), Exploration Manager and Technical Advisor of the company and considered a Qualified Person for the purposes of NI 43-101.

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Marks Key Step Defining Montauban’s Full Scale with 70 Km2 District-Scale ANT Survey, and Closes C$7.2 Million Offering

Disseminated on behalf of  ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

  • ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties, recently announced launch of a 70 km2 district-scale ANT survey at its flagship Montauban Gold-Silver Project in Québec
  • This marks the second phase of the survey, with the initial one having covered 10 km2, completed in 2025
  • The expanded program is to confirm whether the interpreted structural corridor continues along strike, and marks a pivotal stage for the company in understanding the broader geological framework of Montauban
  • ESGold also closed its recent LIFE Offering, raising gross proceeds of C$7.2 million

ESGold (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, announced the launch of a 70 square kilometers district-scale Ambient Noise Topography (“ANT”) survey at its flagship Montauban Gold-Silver Project in Québec. It represents the second phase of a survey, which originally covered only 10 km2 and was completed in 2025. Results from this initial survey formed the basis of ESGold’s integrated 3D geological model, which has been integral in highlighting Montauban’s full potential (https://ibn.fm/iCgW4).

“This next phase marks an important step in defining the full scale of Montauban,” noted Gordon Robb, ESGold’s CEO.

“Our initial ANT survey and integrated 3D model revealed a deep and expanding mineralized corridor extending to approximately 900 meters and over at least two kilometers of strike. The expanded 70 square kilometer program is seven times larger than our initial survey and represents the most comprehensive geophysical assessment ever conducted across the Montauban district,” he added (https://ibn.fm/iCgW4).

This expanded survey program looks to confirm whether the interpreted structural corridor continues along strike. It is also designed to assess the potential for additional mineralized lenses within the broader framework. It will deliver high-resolution, three-dimensional subsurface imaging across a significant portion of the company’s newly consolidated land package. It will also help define high-priority drill targets for future exploration, while further assessing the size, shape, and continuity of mineralized anomalies.

“For the first time in the project’s history, this land package has been consolidated under one operator and is being evaluated using modern, deep-penetrating geophysical tools,” Robb noted. “We believe we are at a pivotal stage in understanding the broader geological framework of Montauban,” he concluded (https://ibn.fm/iCgW4).

The company also recently announced the closing of its brokered LIFE offering, raising gross proceeds of C$7.2 million. The offering involved the sale of 10,683,000 units of the company at C$0.68 per unit, with Red Cloud Securities Inc. acting as the sole agent and bookrunner. ESGold intends to direct the net proceeds from the offering to the advancement of its Montauban project, as well as general working capital and corporate purposes. 

For company information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

Safe Pro Group Inc. (NASDAQ: SPAI) Completes Delivery of AI Edge Processing System to the U.S. Government, and Announces a Drone Inspection Contract with a Multinational Telecommunications Firm

  • Security and defense company Safe Pro Group recently announced that it has executed full delivery of the company’s AI-powered edge processing systems to the U.S. Government.
  • The delivery proved that the company can rapidly execute contracts under U.S. Government programs, as it delivered these systems 15 days after the receipt of the award.
  • SPAI also announced that the company’s subsidiary, Airborne Response, LLC, has gotten a purchase order from a multinational telecommunications firm to provide aerial inspections and asset management services.

Safe Pro Group (NASDAQ: SPAI), a tech company that delivers security and defense solutions, recently announced that it has completed the full delivery of the company’s AI-powered edge processing systems valued at $1 million to the U.S. Government (https://ibn.fm/hNZEA). Safe Pro Group’s AI-powered edge processing systems are tactical, hardware-based units able to analyze drone imagery and sensor data quickly in communication-restricted or denied environments.

The company executed this delivery just 15 days after receiving the award, representing an operational milestone as SPAI as it advances commercialization of its patented AI product portfolio.

Speaking about the delivery, Safe Pro Group CEO, Dan Erdberg, said “Delivering in 15 days from the receipt of our award demonstrates Safe Pro’s ability to rapidly execute on contracts under U.S. Government programs, building confidence in our capabilities and establishing a critical past performance track record with customers.”

Following this contract, Safe Pro continues to pursue additional opportunities with U.S. Government agencies, prime contractors, and allied international partners.

In addition to completing this delivery, SPAI’s Mission Critical Unmanned Solutions subsidiary, Airborne Response, LLC, has received a purchase order from a multinational telecommunications firm (https://ibn.fm/IakcE). The company has been tasked with providing unmanned aircraft systems (“UAS”) aerial inspection and asset management services supporting communication infrastructure that’s used by first responders in South Florida. Under the program, Airborne Response will deploy FAA-compliant UAS flight teams to conduct comprehensive aerial inspections of emergency communication towers. The company will inspect antennas, connections, and structural components, while also providing georeferenced imaging, asset documentation, and power line pathway inspections to support operational readiness.

These inspections are designed to make sure the radio communications infrastructure that first responders rely on are both reliable and resilient. This engagement expands Safe Pro’s operational rollout of the company’s drone-based intelligence platform and builds on SPAI’s strategy to build one of the industry’s largest real-world aerial data pipelines to support next-gen computer vision AI models.

Speaking about the purchase order, Erdberg said “This purchase order, supporting vital communications infrastructure, highlights the increasing role of drone technology in mission-critical public safety operations, and importantly, provides us with a unique opportunity to utilize our drone services to directly fuel the growth of our AI platform with real world data.”

About Safe Pro Group Inc. (NASDAQ: SPAI)

Safe Pro Group is a mission-driven tech company that develops and delivers security and defense solutions to customers in the humanitarian, law enforcement, homeland security, defense, and commercial markets. At the core of SPAI’s mission is the company’s patented computer vision technology that rapidly detects and identifies small explosive objects in drone footage, to enable safer and more efficient field operations for teams on the ground.

For more information, visit the company’s website at www.SafeProGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAI are available in the company’s newsroom at https://ibn.fm/SPAI

Renewal Fuels Inc. (RNWF) Expands Patent Portfolio for Texatron(TM) and Strengthens Leadership as It Develops Commercial Path for Fusion Energy Technology

  • Eight new patent applications have been filed covering reactor geometry, electromagnetic confinement, and control systems related to the Texatron(TM) fusion platform for energy generation, securing protection across reactor architecture, fuel management, and integrated energy systems as the company’s fusion technology development progresses.
  • The company’s strategy focuses on generating revenue through energy partnerships and contractual structures in advance of full fusion power deployment.
  • Electrical engineer Andrew S. Mikulski has joined the board as an independent director.
  • Energy markets specialist Sebastian E. Hoyos has been appointed Chief Revenue Officer to lead commercialization strategy.

Renewal Fuels (OTC: RNWF) (d/b/a American Fusion), an advanced energy platform company focused on the development and commercialization of fusion energy technologies, is expanding its intellectual property portfolio and leadership team as it pursues the development and commercialization of its Texatron(TM) fusion energy platform.

The Texas-based company recently announced the filing of eight additional patent applications with the U.S. Patent and Trademark Office related to the Texatron reactor architecture (https://ibn.fm/WRGDr). The new applications cover several technical components of the reactor system, including toroidal chamber designs, clamshell housing structures, electromagnetic confinement elements, and electronic control systems that regulate pulsed energy inputs.

Management said the filings expand the intellectual property framework supporting the Texatron architecture, which is being developed as a modular fusion system intended for eventual industrial and grid applications.

The patent expansion forms part of a broader strategy to secure layered protection across several aspects of the technology. According to the company, the intellectual property approach targets multiple areas, including reactor geometry, electromagnetic confinement methods, fuel cycle management, and integrated system design. These protections are intended to evolve alongside engineering development and eventual commercial deployment.

Brent Nelson, chief executive of Kepler Fusion Technologies, said the patent portfolio is being built to align with ongoing design refinements. “Our intellectual property strategy is being built deliberately around the core architecture of the Texatron system,” Nelson said in the company update. Each patent filing is intended to protect structural and system-level elements of the reactor design while supporting future commercialization options. “As development progresses, we expect the portfolio to continue expanding in parallel with ongoing engineering refinement and validation,” Nelson added. 

The company previously disclosed that twenty patent applications had already been filed covering key structural and electromagnetic aspects of the Texatron platform. The additional filings bring the portfolio further along as development work continues.

Alongside the patent update, the company announced two senior appointments aimed at strengthening governance and commercialization capabilities.

The first is the appointment of Andrew S. Mikulski as an independent member of the board of directors. Mikulski, an electrical engineer with experience in power electronics and advanced electrical systems, joined the board effective March 6, 2026.

He currently serves as product manager for magnetics, sensors and actuators at KEMET Electronics Corporation, a subsidiary of Yageo Corporation. In that role, he oversees electromagnetic component technologies used in power conversion systems, industrial automation platforms, and sensing applications. Earlier in his career, Mikulski worked as an electrical engineer at Textron Systems, where he contributed to testing and integration work on defense technology platforms. He also serves as co-chair of the Power Sources Manufacturers Association capacitor committee, where he participates in technical collaboration and industry standards development.

Company leadership said his background in electrical system architecture and high-reliability engineering will provide technical oversight at the board level as the Texatron platform advances. 

Richard Hawkins, chief executive of Renewal Fuels, said the appointment strengthens the board’s technical perspective as the company develops its fusion system. “Andrew brings a strong engineering foundation and practical experience working with complex electrical systems used in demanding environments such as aerospace, defense, and industrial infrastructure,” Hawkins said. “As the company continues advancing the Texatron platform, having board level oversight from individuals who understand power electronics, system architecture, and engineering commercialization adds meaningful depth to the company’s governance and technical perspective.”

The company also moved to expand its commercial leadership by appointing Sebastian E. Hoyos as Chief Revenue Officer (https://ibn.fm/T4eE2). Hoyos brings more than fifteen years of experience structuring bankable commercial energy agreements across regulated and deregulated electricity markets. His work has focused on developing long-term power purchase agreements and energy supply contracts with corporate and institutional energy buyers.

Prior to joining American Fusion, Hoyos served as head of renewable energy solutions at Diverxia, where he led corporate energy origination efforts and negotiated power offtake agreements. Earlier roles included heading renewable energy strategy for the Americas at ENGIE Impact and managing a large portfolio of renewable energy contracts during his tenure at Walmart. At Walmart he oversaw more than four hundred energy agreements covering solar, wind, storage, fuel cells, and electric vehicle infrastructure projects.

The company said Hoyos will lead the commercialization strategy for the Texatron technology platform, including the development of energy partnerships and long-term contract structures. This commercial planning is intended to position the company for revenue opportunities prior to full technology deployment.

Management indicated that much of the administrative groundwork following the merger between Renewal Fuels and Kepler Fusion Technologies has been completed, allowing the company to shift greater focus toward product development and commercial strategy.

“Sebastian’s experience negotiating power purchase agreements and working across both regulated and deregulated energy markets provides valuable commercial expertise as we continue developing the Texatron platform,” Nelson said. “With much of our first quarter groundwork now behind us, we are keen to focus on uplisting to a listed exchange and are laser focused on building fundamental value and revenue in the company to enhance shareholder value.”

Hoyos underlined that the Texatron represents a paradigm shift in technology that only happens once in someone’s lifetime. “I truly believe this is the greatest invention since man harnessed fire. Fusion energy has the potential to redefine how the world produces and consumes power, and I look forward to building the revenue platform that will help bring this breakthrough technology to customers across the globe,” Hoyos added. 

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to RNWF are available in the company’s newsroom at https://ibn.fm/RNWF

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Advances Rare Earth Portfolio with High-Grade Results in Colorado and Active Drilling in Brazil

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

  • Canamera Energy Metals recently confirmed elevated rare earth oxide values at its Iron Hills Project in Colorado, including assays up to 6,557 ppm TREO.
  • EMETF operates at the nexus of critical minerals exploration, secure jurisdictions, and diversified project development.
  • These updates underscore the company’s broader mission: building a multi-asset rare earths platform aligned with global supply chain realignment.

Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) is consolidating its efforts to execute its strategy of advancing a diverse portfolio of rare earth and critical metals projects across select geopolitically stable regions. Exploration updates from South and North America underscore the firm’s dual-pronged approach: the systematic advancement of priority assets toward resource definition and early-stage discovery, backed by strategic technical validation.

At the company’s Iron Hills Project in Gunnison County, Colorado, Canamera recently reported over-limit re-assay results that show high rare earth concentrations from its initial prospecting program. Follow-up sodium peroxide fusion analysis indicates a total rare earth oxide value of 6,557, including 2,336 ppm neodymium, a vital magnet rare earth element. Further samples showed heavy rare earth oxide values as much as 2,841, resulting from increased yttrium content (ibn.fm/8xYTX).

Six samples from the initial prospecting have so far returned TREO values more than 3,000 ppm. The frequency, strength, and elemental diversity of the results show a fertile rare earth system. The company’s management has highlighted that these results will help with follow-up work, including expanded sampling and the evaluation of airborne radiometric, magnetic, and electromagnetic surveys to better define mineralization controls.

Iron Hills is a vital American-based asset, especially at a time when domestic sources of rare earth metals are gaining traction. With the increased demand for wind energy, electric vehicles, and advanced electronics creating more need for magnet metals like neodymium, projects located in jurisdictions like Colorado come with strategic relevance.

In addition to this early-stage success, the company is also making significant progress through its Turvolândia rare earth project in Brazil, where Canamera is carrying out a maiden drill program. The first phase of drilling, comprising about 1,000 meters, will test the continuity and thickness of near-surface iconic clay-hosted rare earth mineralization across three core areas. This has attracted attention globally because of its potential for lower-cost extraction compared to what is obtainable with conventional hard-rock rare earth deposits (ibn.fm/aotFi).

Turvolândia is located close to the Poços de Caldas alkaline complex, an area quickly emerging as one of Brazil’s most prospective ionic clay rare earth districts. Early-stage drilling focuses on shallow auger holes aimed at weathered clay profiles developed over rare earth-enriched rocks, which are comparable to ion adsorption clay deposits that underpin much of the Chinese rare earth production.

The Turvolândia and Iron Hills updates highlight Canamera’s broader exploration thesis: identifying underexplored, district-scale opportunities spread across the Americas and promoting them using data-driven, methodical programs. The company’s operational portfolio also includes uranium and niobium projects in Wyoming, Ontario, and British Columbia, providing a diversified exposure across commodities and jurisdictions.

For more information, visit the company’s website at canamerametals.com.

NOTE TO INVESTORS: The latest news and updates relating to EMETF are available in the company’s newsroom at ibn.fm/EMETF

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This document contains “forward-looking information” within the meaning of applicable securities legislation, including statements regarding: the Company’s planned exploration activities on its projects; the anticipated timing and completion of the earn-in milestones under the Option Agreement; the Company’s ability to make required cash and share payments and incur required exploration expenditures; the geological prospectivity of its projects; and the Company’s exploration strategy.

Forward-looking information is based on assumptions, estimates, and opinions of management at the date the statements are made and is subject to a variety of risks and uncertainties that could cause actual results to differ materially from those anticipated or projected. These assumptions include, without limitation: the Company’s ability to raise sufficient capital to fund its exploration programs and option payments; favourable regulatory conditions; continued access to its projects; and general economic conditions.

Important risk factors that could cause actual results to differ materially include, but are not limited to: uncertainties related to raising sufficient financing; the inherently speculative nature of mineral exploration; title risks; environmental and permitting risks; and fluctuations in uranium prices. Additional risk factors affecting the Company can be found in the Company’s continuous disclosure documents available at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on forward-looking information.

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

  • LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight against cancer.
  • LIXTE develops LB-100, a drug that enhances the effectiveness of cancer treatments, while Liora has developed a unique cancer treatment that’s believed to be more affordable, precise, and efficient than many traditional options.
  • Together, this pair of products have incredible clinical and commercial potential, to both help the businesses succeed, while also offering better outcomes for patients suffering from cancer.

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, and the company’s subsidiary, Liora Technologies, both develop cancer therapies that, when combined, have the potential to improve outcomes and results for cancer patients.

LIXTE’s flagship product and lead clinical candidate is LB-100, which is a proprietary small-molecule inhibitor of protein phosphatase 2A (“PP2A”). Designed to enhance the activity of chemotherapy and immunotherapy, the compound has developed a favorable safety profile in Phase 1 clinical trials and is supported by more than 25 published preclinical and translational studies.

The compound is currently being evaluated in multiple clinical programs that are targeting solid tumors with limited treatment options.

On the other hand, Liora Technologies develops the Linac for Image Guided Hadron Therapy (“LiGHT”) System. This system is a controlled proton therapy platform that offers many benefits over the other proton therapy methods currently available.

It can be deployed rapidly, is much smaller in size than other options, and is cheaper to build and use. The LiGHT System also works more efficiently as it reduces proton loss, allows for much more precise dosing, and allows you to change energy levels in milliseconds, not seconds. Also, the system controls beams electronically, which eliminates the needs for mechanical energy degraders, which often waste a ton of proton energy.

As you could imagine, there’s plenty of synergy between the two products – as the LB-100 enhances cancer therapies by making cancer cells more vulnerable, it takes an already efficient and powerful LiGHT system and makes it even more effective at fighting cancer. In addition to making cancer cells more susceptible to proton therapy and other types of radiation, LB-100 also stops them from being able to effectively recover after being damaged by the radiation.

This synergy not only helps deliver better outcomes for cancer patients, but also the businesses themselves. There aren’t many solutions out there in proton therapy like the LiGHT system, and the platform is a perfect match with LB-100. The combination could potentially be of great use clinically, which in turn boosts the commercial potential of the pairing, as well.

About LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT)

LIXTE Biotechnology Holdings is a clinical-stage pharmaceutical company developing cancer therapies. Instead of introducing standalone treatments, the company focuses on an approach to enhance the effectiveness of established therapies. The company’s work focuses on improving how treatments like chemotherapy and immunotherapy perform in difficult-to-treat cancers.

For more information, visit the company’s website at https://lixte.com.

NOTE TO INVESTORS: The latest news and updates relating to LIXT are available in the company’s newsroom at ibn.fm/LIXT

Pelican Acquisition Corp. (NASDAQ: PELI) Is ‘One to Watch’

  • Pelican Acquisition Corp. is pursuing a business combination with Greenland Exploration Limited and March GL Company that is expected to close on March 17, 2026, and create a publicly traded energy company named Greenland Energy Company.
  • The proposed company is focused on exploration and development in Greenland’s Jameson Land Basin, where March GL may earn up to a 70% interest in more than 2 million acres of onshore licenses.
  • Historic exploration conducted by Atlantic Richfield collected approximately 1,800 kilometers of seismic data that has since been reprocessed using modern imaging technology.
  • Early geological models suggest the basin could contain more than 13 billion barrels of recoverable oil if exploration results confirm the resource potential.
  • The Arctic region is estimated by the U.S. Geological Survey to contain approximately 13% of the world’s undiscovered conventional oil resources and 30% of its undiscovered conventional natural gas resources.

Pelican Acquisition (NASDAQ: PELI) is a publicly traded special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Pelican has entered into a proposed business combination with Greenland Exploration Limited and March GL Company that is expected to close on March 17, 2026, and result in the creation of Greenland Energy Company, a publicly traded entity focused on the development of energy resources in Greenland’s Jameson Land Basin.

On February 24, 2026, Pelican announced that the U.S. Securities and Exchange Commission had declared effective the company’s registration statement on Form S-4 in connection with the proposed transaction, and Pelican scheduled a shareholder meeting to vote on the business combination.

Greenland Energy Company

Greenland Energy Company is expected to be formed through the business combination of Pelican Acquisition Corp., Greenland Exploration Limited and March GL Company to pursue oil and gas exploration in Greenland’s Jameson Land Basin, one of the last highly prospective yet largely undrilled basins globally, with a scale comparable to many of the world’s major producing regions.

Greenland Exploration Limited

Greenland Exploration Limited is a Texas-based entity focused on developing strategic positions in North American energy assets. Through its partnerships and future acquisitions, the company seeks to deliver long-term shareholder value in a dynamic and evolving energy market.

March GL Company

March GL Company is a privately owned Texas corporation that entered into an agreement with 80 Mile to begin drilling in the Jameson oil and gas basin in Greenland. The company will fund 100% of the costs associated with up to two exploration wells designed to delineate the sedimentary structure and energy potential of the basin.

Through its agreement with 80 Mile and its subsidiary White Flame Energy A/S, March GL may earn up to a 70% interest in three onshore licenses covering more than 2 million acres across the Jameson Land Basin. March GL will also serve as Field Operations Manager for the project.

Market Opportunity

According to the U.S. Energy Information Administration, the Arctic holds an estimated 13% of the world’s undiscovered conventional oil resources, or approximately 90 billion barrels, and 30% of its undiscovered conventional natural gas resources. The commercial development of these resources has historically been limited by the difficulty and cost associated with operating in Arctic environments.

The Jameson Land Basin on Greenland’s east coast represents one of the Arctic regions where exploration has historically been limited despite significant geological interest. Historic exploration campaigns conducted by Atlantic Richfield in the 1980s collected approximately 1,800 kilometers of seismic data and identified geological structures capable of trapping large volumes of hydrocarbons.

Greenland Energy’s exploration team has reprocessed this seismic data using modern imaging technology and identified more than 50 potential oil and gas targets within the basin. Early geological models suggest the basin could contain more than 13 billion barrels of recoverable oil if exploration results confirm the resource potential.

Leadership Team

Robert Price, Chief Executive Officer of March GL Company and incoming Chief Executive Officer of Greenland Energy Company, has assembled and managed companies across the energy, real estate and manufacturing sectors. He founded Brooks Energy Company in 1991 and previously served as Vice President, Trust Officer and Oil and Gas Trust Energy Department Manager at the First National Bank and Trust Company of Tulsa, now J.P. Morgan Chase Bank. At March GL, he oversaw the reprocessing of approximately 1,800 kilometers of historic seismic data from Greenland’s Jameson Land Basin.

Larry G. Swets Jr., Chief Executive Officer of Greenland Exploration Limited and incoming Executive Chairman of Greenland Energy Company, has been involved in advancing the development of energy resources in Greenland’s Jameson Land Basin through Greenland Exploration’s planned merger with March GL Company and Pelican Acquisition Corp.

For more information, visit the company website at https://pelicanacq.com.

NOTE TO INVESTORS: The latest news and updates relating to PELI are available in the company’s newsroom at https://ibn.fm/PELI

Trilogy Metals Inc.’s Joint Venture, Ambler Metals, Strengthens Management as U.S. Mineral Policy Gains Momentum

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

  • Trilogy Metals has expanded its management structure with new leadership appointments at its Ambler Metals Joint Venture with South32 Limited, to support operational execution and strategic planning.
  • Ambler Metals’ focus under an expanded leadership team is the development of mineral resources in the Ambler Mining District of northwest Alaska.
  • The announcement comes just as U.S. policymakers are placing renewed emphasis on domestic resource development.

Growing concerns over supply chain security and the energy transition have pushed domestic critical minerals production to the forefront of U.S. policy discussions. Copper, zinc and other metals essential to electrification, energy infrastructure and advanced manufacturing are increasingly viewed as strategic resources. Against this backdrop, Ambler Metals recently expanded its management team, a move announced by Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) that is intended to strengthen leadership as the joint venture advances mineral development initiatives for the Upper Kobuk Mineral Projects in Alaska’s Ambler Mining District while navigating a rapidly evolving policy landscape. 

The additions are designed to enhance its ability to move projects forward while strengthening corporate governance, community engagement and operational oversight. Leadership experience in areas such as project development, finance and regulatory engagement is particularly important for companies working in complex mining jurisdictions where permitting, environmental studies and stakeholder coordination are essential components of project advancement.

Two key deposits within the Upper Kobuk Mineral Projects are the Arctic deposit and the Bornite deposit. The Arctic deposit has been described by the company as one of the highest-grade undeveloped copper-dominant polymetallic deposits in the world, containing significant quantities of copper, zinc, lead, gold and silver. The nearby Bornite deposit is another large copper resource that has been the subject of exploration drilling and geological evaluation. Together, these assets form the backbone of Trilogy’s long-term development strategy.

Michael Galicki and Cole Schaeffer bring strong experience in exploration and operational management, respectively, in challenging North American environments, positioning the joint venture to efficiently execute its near-term milestones and target high-priority resource expansion areas. Jenna Tan adds financial and commercial expertise from leading South32’s Hermosa project, strengthening Ambler Metals’ capacity to advance toward an investment decision on the Arctic Project. Meanwhile, Ron Rimelman’s four decades of permitting experience will be critical in navigating the FAST-41 federal permitting process. Together, this leadership team equips Ambler Metals to unlock the full potential of the Upper Kobuk Mineral Projects.

The expansion of Ambler Metals’ management team reflects the growing complexity of advancing large-scale mining projects in today’s regulatory and economic environment. Moving a project from exploration through feasibility studies and into potential construction requires expertise across engineering, environmental science, regulatory affairs and community engagement. By strengthening its leadership bench, the joint venture looks to position itself to navigate these challenges more effectively while preparing for future development phases.

The recent announcement comes just as U.S. policymakers are placing renewed emphasis on domestic resource development. Federal agencies have increasingly identified critical minerals as essential to national security and economic competitiveness. Copper, for example, is a cornerstone material for electrification, energy infrastructure and AI data centers due to its high electrical conductivity and durability.

Recent federal policy developments highlight this shift. The U.S. Department of the Interior has announced that approximately 2.1 million acres in Alaska’s Dalton Corridor would be opened to mining and energy development opportunities as part of a broader effort to strengthen domestic resource production. The department stated that the initiative is intended to support development of natural resources while helping secure critical minerals needed for energy technologies and national infrastructure.

Although the Dalton Corridor initiative is separate from Upper Kobuk Mineral Projects, the policy direction underscores broader federal interest in exploring Alaska’s mineral potential. Alaska is believed to contain significant untapped mineral resources, and the region has long been considered an important frontier for domestic mining development.

This evolving policy environment could present new opportunities capable of supplying metals needed for electrification and infrastructure development, receiving increased attention from governments and investors alike. Copper demand is expected to remain strong as global energy systems shift toward electrification and increase demand on the grid, which require large quantities of conductive materials.

Trilogy Metals has stated that its strategy centers on advancing the Upper Kobuk Mineral Projects through Ambler Metals, its 50/50 joint venture with South32, while continuing technical work, environmental studies and community engagement required for future development. The company’s approach reflects a long-term vision of contributing to domestic supplies of critical minerals while operating within evolving regulatory frameworks.

Beyond the Arctic and Bornite deposits, the Ambler Mining District contains multiple mineral prospects that have been explored over decades by various companies and federal agencies. The region is recognized for its rich polymetallic mineralization, which has attracted sustained interest from the mining industry.

Ambler Metals’ management expansion can be viewed as part of a broader effort to prepare the company for the next stages of project advancement. As mining companies respond to growing demand for critical minerals and navigate increasingly complex regulatory environments, strong leadership teams are essential for managing technical development, securing financing and maintaining stakeholder relationships.

For more information, visit www.TrilogyMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to Trilogy Metals are available in the company’s newsroom at ibn.fm/TMQ

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

March 20, 2026

Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and unmet medical needs, recently received such recognition as its […]

Rotate your device 90° to view site.